Piper Sandler reiterated their overweight rating on shares of Align Technology (NASDAQ:ALGN – Free Report) in a report issued on Thursday morning, Benzinga reports. The firm currently has a $375.00 target price on the medical equipment provider’s stock, up from their prior target price of $355.00. Other equities research analysts have also issued reports about […]